Cartesian Therapeutics, Inc. Common Stock (NASDAQ: RNAC) last traded at $10.04, down 1.86% on the session. The quote above updates while this page is open; the figures below are drawn from Cartesian Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Cartesian Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker RNAC. Its market capitalisation is $303.76 million.
Valuation measures for Cartesian Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $303.76M |
|---|---|
| Enterprise value | $600.01M |
| Price / sales | 205.66 |
| Beta | 1.63 |
Trailing-twelve-month figures tagged in Cartesian Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.48M |
|---|---|
| Net income (TTM) | -$151.89M |
| EPS (TTM) | -$5.84 |
| Operating margin | -10518.55% |
| Cash | $147.61M |
Range and volume for RNAC over the past 52 weeks.
| 52-week high | $11.39 |
|---|---|
| 52-week low | $5.60 |
| Volume | 163.4K |
| Average volume | 266.2K |
| Previous close | $10.23 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.